These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 36809849

  • 1. Prevalence of bloodstream infection pathogens in hemato-oncological patients and predictors of carbapenem-resistant gram-negative bacterial infections during febrile neutropenia.
    Schonardie AP, Beck E, Rigatto MH.
    Braz J Infect Dis; 2023; 27(2):102758. PubMed ID: 36809849
    [Abstract] [Full Text] [Related]

  • 2. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R, Estaitieh N, Mugharbil A, Jisr T, Abdallah DI, Ziade F, Sinno L, Ibrahim A.
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [Abstract] [Full Text] [Related]

  • 3. Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome.
    Ozsurekci Y, Aykac K, Cengiz AB, Basaranoglu ST, Sancak B, Karahan S, Kara A, Ceyhan M.
    Diagn Microbiol Infect Dis; 2017 Apr; 87(4):359-364. PubMed ID: 28089138
    [Abstract] [Full Text] [Related]

  • 4. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
    El Omri H, Padmanabhan R, Taha RY, Kassem N, Elsabah H, Ellahie AY, Santimano AJJ, Al-Maslamani MA, Omrani AS, Elomri A, El Omri A.
    J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
    Khoo AL, Zhao YJ, Teng M, Ying D, Jin J, Chee YL, Poon LM, Lim SE, Koh LP, Chng WJ, Lim BP, Hsu LY, Chai LYA.
    Int J Antimicrob Agents; 2018 Sep; 52(3):350-357. PubMed ID: 29751120
    [Abstract] [Full Text] [Related]

  • 6. Gram-negative bacteremia, the risk factors, and outcome in children.
    Gumus DD, Demir OO, Aykac K, Hazirolan G, Avci H, Ceyhan M, Cengiz AB, Ozsurekci Y.
    Diagn Microbiol Infect Dis; 2024 Jul; 109(3):116324. PubMed ID: 38733752
    [Abstract] [Full Text] [Related]

  • 7. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017.
    Zhang D, Hu S, Sun J, Zhang L, Dong H, Feng W, Lei J, Dong Y.
    J Infect Public Health; 2019 Jul; 12(2):195-199. PubMed ID: 30385238
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study.
    Wang L, Wang Y, Fan X, Tang W, Hu J.
    Medicine (Baltimore); 2015 Nov; 94(45):e1931. PubMed ID: 26559260
    [Abstract] [Full Text] [Related]

  • 9. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?
    Joncour A, Puyade M, Michaud A, Tourani JM, Cazenave-Roblot F, Rammaert B.
    Support Care Cancer; 2020 Jul; 28(7):3103-3111. PubMed ID: 31667604
    [Abstract] [Full Text] [Related]

  • 10. The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia.
    Clerici D, Oltolini C, Greco R, Ripa M, Giglio F, Mastaglio S, Lorentino F, Pavesi F, Farina F, Liberatore C, Castiglion B, Tassan Din C, Bernardi M, Corti C, Peccatori J, Scarpellini P, Ciceri F, Castagna A.
    Int J Antimicrob Agents; 2021 Jun; 57(6):106335. PubMed ID: 33838223
    [Abstract] [Full Text] [Related]

  • 11. Investigation and analysis of carbapenem-resistant gram-negative bacterial infection rates across hospitals in Shandong Province in China.
    Liu K, Xu H, Sun J, Liu Y, Li W.
    Front Public Health; 2022 Jun; 10():1014995. PubMed ID: 36420011
    [Abstract] [Full Text] [Related]

  • 12. The prospective evaluation of risk factors and clinical influence of carbapenem resistance in children with gram-negative bacteria infection.
    Sahbudak Bal Z, Bekmezci N, Soylu M, Sen S, Avcu G, Aydemir S, Vardar F.
    Am J Infect Control; 2018 Feb; 46(2):147-153. PubMed ID: 28982610
    [Abstract] [Full Text] [Related]

  • 13. Development and validation of nomograms for predicting the risk probability of carbapenem resistance and 28-day all-cause mortality in gram-negative bacteremia among patients with hematological diseases.
    Jian X, Du S, Zhou X, Xu Z, Wang K, Dong X, Hu J, Wang H.
    Front Cell Infect Microbiol; 2022 Feb; 12():969117. PubMed ID: 36683699
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of bacterial bloodstream infections and association between neutropenia and 30-day mortality among oncology inpatients at a university hospital in Saudi Arabia.
    Binkhamis K, Aldakhil I, Alhawas A, Alsaleh A, Albaroudi A, Almuhanna B, Makkawi M, Alzahrani M.
    Ann Saudi Med; 2023 Feb; 43(3):172-178. PubMed ID: 37270682
    [Abstract] [Full Text] [Related]

  • 15. Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain.
    Ferrer R, Fariñas MC, Maseda E, Salavert M, Bou G, Díaz-Regañón J, López D, Lozano V, Gómez-Ulloa D, Fenoll R, Lara N, McCann E.
    Rev Esp Quimioter; 2021 Dec; 34(6):639-650. PubMed ID: 34806858
    [Abstract] [Full Text] [Related]

  • 16. An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality.
    Kara Ali R, Surme S, Balkan II, Salihoglu A, Sahin Ozdemir M, Ozdemir Y, Mete B, Can G, Ar MC, Tabak F, Saltoglu N.
    Ann Hematol; 2020 Aug; 99(8):1925-1932. PubMed ID: 32564194
    [Abstract] [Full Text] [Related]

  • 17. Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.
    Andria N, Henig O, Kotler O, Domchenko A, Oren I, Zuckerman T, Ofran Y, Fraser D, Paul M.
    J Antimicrob Chemother; 2015 Nov; 70(11):3146-53. PubMed ID: 26209312
    [Abstract] [Full Text] [Related]

  • 18. Rectal colonization with multidrug-resistant gram-negative bacteria in patients with hematological malignancies: a prospective study.
    Kömürcü B, Tükenmez Tigen E, Toptaş T, Fıratlı Tuğlular T, Korten V.
    Expert Rev Hematol; 2020 Aug; 13(8):923-927. PubMed ID: 32574123
    [Abstract] [Full Text] [Related]

  • 19. Nosocomial Non-fermentative gram negative bacteria bloodstream infections in children; Risk factors and clinical outcomes of carbapenem resistance.
    Guner Ozenen G, Sahbudak Bal Z, Umit Z, Avcu G, Tekin D, Kurugol Z, Cilli F, Ozkinay F.
    J Infect Chemother; 2021 May; 27(5):729-735. PubMed ID: 33454215
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.